News / Taiwan / economic_daily
Lotus Pharmaceutical Shares Surge 5.66% Amid Post-Election Biotech Rally
Health Technology · Pharmaceuticals: Major · economic_daily · 2026-11-05
1795
Lotus Pharmaceutical shares climbed over 5% today as investor sentiment in the biotech sector improved following the U.S. election, supported by strong foreign buying.
What Happened
Stock Performance: Lotus Pharmaceutical shares saw strong momentum today, climbing to an intraday high of NT$174.5. Despite some profit-taking toward the close, the stock finished at NT$168, marking a 5.66% gain on a volume of 3,380 shares.
Market Sentiment: Following the U.S. election, investor optimism regarding the biotech sector has increased. This shift in sentiment has made biotech stocks a focal point for market participants, with Lotus serving as a key indicator.
Foreign Investment: Foreign institutional buying has been a primary driver for Lotus's recent price action. Analysts suggest that foreign investors are increasingly bullish on pharmaceutical companies with strong international competitive advantages.
Outlook: Market participants are closely monitoring the stock's technical levels and continued foreign capital flows. Increased trading volume suggests sustained interest, which could support further upside if the stock maintains its current support levels.
Read original
More in Health Technology
Health Technology · economic_daily · 2026-11-05
ScinoPharm reported a 70% year-over-year increase in net profit for the first nine months, driven by investment gains, and anticipates Q4 revenue growth from its new production capacity.
4167
Health Technology · economic_daily · 2026-11-05
PharmaEssentia reported record-high October revenue of 2.84 billion TWD, driven by robust U.S. sales of its Ropeg injection pen and expansion into the ET market.
6446
Health Technology · economic_daily · 2026-11-05
US healthcare stocks surged on expectations of favorable policy continuity following Democratic election gains, fueling a rally in Taiwan's biotech sector, led by strong earnings and new product approvals from companies like Bora Pharmaceuticals.
1786, 1795, 6446, 6472, 6782, 6919, 6949
Latest in Taiwan
Consumer Durables · economic_daily · 2026-11-05
Yulon Motor faces market headwinds amid intense competition, while its subsidiary Chailease Holding maintains steady growth through effective risk management.
2201, 9941
Electronic Technology · economic_daily · 2026-11-05
Taiwan stocks plummeted by 1,374 points amid global tech sell-offs, leading to a single-day reduction of NT$27.4 billion in margin debt as market volatility intensifies.
Transportation · economic_daily · 2026-11-05
Logistics firm Jianxin International reported a strong third quarter with EPS of NT$1.12, driven by expansion into AI and semiconductor supply chain services.
8367
Electronic Technology · economic_daily · 2026-11-05
Semiconductor process supply system provider Pengyi reported record-breaking Q3 financial results and announced a cash dividend of NT$5 per share for H1 2026.
6613